Response to treatment of myasthenia gravis according to clinical subtype-Reference-Cited by-同舟云学术

Response to treatment of myasthenia gravis according to clinical subtype

Published:2016-11-17 Issue:1 Volume:16 Page:
ISSN:1471-2377
Container-title:BMC Neurology
language:en
Short-container-title:BMC Neurol

Author:

Akaishi Tetsuya,Suzuki Yasushi,Imai Tomihiro,Tsuda Emiko,Minami Naoya,Nagane Yuriko,Uzawa Akiyuki,Kawaguchi Naoki,Masuda Masayuki,Konno Shingo,Suzuki Hidekazu,Murai Hiroyuki,Aoki Masashi,Utsugisawa Kimiaki

Publisher

Springer Science and Business Media LLC

Subject

Neurology (clinical),General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12883-016-0756-3.pdf

Reference20 articles.

1. Vincent A, Leite MI. Neuromuscular junction autoimmune disease: muscle specific kinase antibodies and treatments for myasthenia gravis. Curr Opin Neurol. 2005;18:519–25.

2. Meriggioli MN, Sanders DB. Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity. Lancet Neurol. 2009;8:475–90.

3. Evoli A, Batocchi AP, Minisci C, Di Schino C, Tonali P. Clinical characteristics and prognosis of myasthenia gravis in older people. J Am Geriatr Soc. 2000;48:1442–8.

4. Grob D, Arsura EL, Brunner NG, Namba T. The course of myasthenia gravis and therapies affecting outcome. Ann N Y Acad Sci. 1987;505:472–99.

5. Lavrnic D, Losen M, Vujic A, De Baets M, Hajdukovic LJ, Stojanovic V, et al. The features of myasthenia gravis with autoantibodies to MuSK. J Neurol Neurosurg Psychiatry. 2005;76:1099–102.

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterizing Myasthenia Gravis Symptoms, Exacerbations, and Crises From Neurologist's Clinical Notes Using Natural Language Processing;Cureus;2024-07-30

2. Real-World Case Series of Efgartigimod for Japanese Generalized Myasthenia Gravis: Well-Tailored Treatment Cycle Intervals Contribute to Sustained Symptom Control;Biomedicines;2024-05-30

3. Rituximab for myasthenia gravis;Cochrane Database of Systematic Reviews;2023-04-05

4. Anti-dsDNA Is Associated with Favorable Prognosis in Myasthenia Gravis: A Retrospective Study;Acta Neurologica Scandinavica;2023-03-02

5. Autoantibody detection by a live cell-based assay in conventionally antibody-tested triple seronegative Myasthenia gravis;Neuromuscular Disorders;2023-02